Predicting Brain Amyloid Positivity from T1 weighted brain MRI and MRI-derived Gray Matter, White Matter and CSF maps using Transfer Learning on 3D CNNs

Abnormal β-amyloid (Aβ) accumulation in the brain is an early indicator of Alzheimer’s disease and practical tests could help identify patients who could respond to treatment, now that promising anti-amyloid drugs are available. Even so, Aβ positivity (Aβ+) is assessed using PET or CSF assays, both...

Descripción completa

Detalles Bibliográficos
Autores principales: Chattopadhyay, Tamoghna, Ozarkar, Saket S., Buwa, Ketaki, Thomopoulos, Sophia I., Thompson, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949045/
https://www.ncbi.nlm.nih.gov/pubmed/36824826
http://dx.doi.org/10.1101/2023.02.15.528705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949045/
https://www.ncbi.nlm.nih.gov/pubmed/36824826
http://dx.doi.org/10.1101/2023.02.15.528705

Ejemplares similares